Skip to main content

Table 2 Characteristics of ambulatory patients and inpatients whose prescriptions of dabigatran were analyzed

From: Impact of Pharmacists’ audit on improving the quality of prescription of dabigatran etexilate methanesulfonate: a retrospective study

Variables Ambulant patients (n = 131) Inpatients (n = 97) P value
Age (years) 71 ± 9 70 ± 12 NS
Male (%) 96 (73) 64 (66) NS
ALT (IU/L) 22 ± 12 26 ± 22 NS
AST (IU/L) 25 ± 11 29 ± 17 0.01
ALP (IU/L) 242 ± 76 238 ± 80 NS
Serum creatinine (mg/dL) 1.2 ± 0.2 [130] 1.0 ± 0.3 0.02
eGFR (mL/min/1.73 m2) 64 ± 14 [130] 69 ± 18 0.03
Height (cm) 162 ± 10 [47] 161 ± 10 [77] NS
Weight (kg) 61 ± 12 [50] 60 ± 13 [80] NS
Body surface area (m2) 1.6 ± 0.2 [47] 1.6 ± 0.2 [77] NS
Numbers of concomitant medication 4.6 ± 3.5 4.2 ± 3.2 NS
  1. Data are expressed as means ± SD. Numbers of patients whose data were available are given in brackets. Data without bracket indicate that data were available from all patients in each group. Statistical analyses were performed with the Student’s t-test for continuous variables and with the Chi-squared test for gender ratio
  2. Abbreviations: ALT alanine aminotranferase, AST aspartate aminotransferase, ALP alkaline phosphatase, NS not significant